The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection
Open accessAbstract
Background & aims There is substantial interest in liquid biopsy approaches for cancer early detection among subjects at risk, using multi-marker panels. CA19-9 is an established circulating biomarker for pancreatic cancer; however, its relevance for pancreatic cancer early detection or for monitoring subjects at risk has not been established.Methods CA19-9 levels were assessed in blinded sera from 175 subjects collected up to 5 years before diagnosis of pancreatic cancer and from 875 matched controls from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. For comparison of performance, CA19-9 was assayed in blinded independent sets of samples collected at diagnosis from 129 subjects with resectable pancreatic cancer and 275 controls (100 healthy subjects; 50 with chronic pancreatitis; and 125 with noncancerous pancreatic cysts). The complementary value of 2 additional protein markers, TIMP1 and LRG1, was determined.Results In the PLCO cohort, levels of CA19-9 increased exponentially starting at 2 years before diagnosis with sensitivities reaching 60% at 99% specificity within 0 to 6 months before diagnosis for all cases and 50% at 99% specificity for cases diagnosed with early-stage disease. Performance was comparable for distinguishing newly diagnosed cases with resectable pancreatic cancer from healthy controls (64% sensitivity at 99% specificity). Comparison of resectable pancreatic cancer cases to subjects with chronic pancreatitis yielded 46% sensitivity at 99% specificity and for subjects with noncancerous cysts, 30% sensitivity at 99% specificity. For prediagnostic cases below cutoff value for CA19-9, the combination with LRG1 and TIMP1 yielded an increment of 13.2% in sensitivity at 99% specificity (P = .031) in identifying cases diagnosed within 1 year of blood collection.Conclusion CA19-9 can serve as an anchor marker for pancreatic cancer early detection applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CA19–9 elevations can be observed in plasma samples obtained in the pre-diagnostic setting, suggesting a potential window of opportunity for early detection38.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783
Self-citationInternational consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
Tanaka, M., Fernández-del Castillo, C., Adsay, V., Chari, S., Falconi, M., Jang, J.-Y., Kimura, W., Levy, P., Pitman, M. B., Schmidt, C. M., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.04.004 · Cited by 2,354
Self-citationRyan, D. P., Hong, T. S., & Bardeesy, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404198 · Cited by 2,348
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Rawla, P., Sunkara, T., & Gaduputi, V. (2019) · World Journal of Oncology · doi:10.14740/wjon1166 · Cited by 2,269
Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.22 · Cited by 1,982
Liu, M. C., Oxnard, G. R., Klein, E. A., Swanton, C., Seiden, M. V., Liu, M. C., Oxnard, G. R., Klein, E. A., Smith, D., Richards, D., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.02.011 · Cited by 1,495
Self-citation
Cited by
Sorted by citations
Park, W., Chawla, A., & O'Reilly, E. M. (2021) · JAMA · doi:10.1001/jama.2021.13027 · Cited by 2,040
Pancreatic cancer: Advances and challenges
Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321
Self-citationPancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment
Wood, L. D., Canto, M. I., Jaffee, E. M., & Simeone, D. M. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.03.056 · Cited by 918
Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis
Cai, J., Chen, H., Lu, M., Zhang, Y., Lu, B., You, L., Zhang, T., Dai, M., & Zhao, Y. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.06.027 · Cited by 495
Large-scale pancreatic cancer detection via non-contrast CT and deep learning
Cao, K., Xia, Y., Yao, J., Han, X., Lambert, L., Zhang, T., Tang, W., Jin, G., Jiang, H., Fang, X., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02640-w · Cited by 358
Pancreatic Cancer Surveillance and Survival of High-Risk Individuals
Blackford, A. L., Canto, M. I., Dbouk, M. H., Hruban, R. H., Katona, B. W., Chak, A., Brand, R. E., Syngal, S., Farrell, J. J., Kastrinos, F., et al. (2024) · JAMA Oncology · doi:10.1001/jamaoncol.2024.1930 · Cited by 178
Self-citationNakamura, K., Zhu, Z., Roy, S., Jun, E., Han, H., Muñoz, R. M., Nishiwada, S., Sharma, G. G., Cridebring, D., Zenhausern, F., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.06.090 · Cited by 174
Advances in the management of pancreatic cancer
Chiaro, M. D., Sugawara, T., Karam, S. D., & Messersmith, W. A. (2023) · BMJ · doi:10.1136/bmj-2022-073995 · Cited by 118
Do alkaline phosphatases have great potential in the diagnosis, prognosis, and treatment of tumors?
Jiang, T., Zeng, Q., & He, J. (2023) · Translational Cancer Research · doi:10.21037/tcr-23-1190 · Cited by 80
Pancreatic Cancer in Chronic Pancreatitis: Pathogenesis and Diagnostic Approach
Cosquer, G. L., Maulat, C., Bournet, B., Cordelier, P., Buscail, É., & Buscail, L. (2023) · Cancers · doi:10.3390/cancers15030761 · Cited by 73
Shi, W., Wartmann, T., Accuffi, S., Al-Madhi, S., Perrakis, A., Kahlert, C., Link, A., Venerito, M., Keitel, V., Bruns, C. J., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02488-4 · Cited by 65
The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy
Sturm, N., Ettrich, T. J., & Perkhofer, L. (2022) · Cancers · doi:10.3390/cancers14010217 · Cited by 68
Research Progress on Leucine-Rich Alpha-2 Glycoprotein 1: A Review
Zou, Y., Xu, Y., Chen, X., Wu, Y., Fu, L., & Lv, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.809225 · Cited by 62
Schepis, T., Lucia, S. S. D., Pellegrino, A., GAUDIO, A. D., Maresca, R., Coppola, G., Chiappetta, M. F., Gasbarrini, A., Franceschi, F., Candelli, M., et al. (2023) · Cancers · doi:10.3390/cancers15133423 · Cited by 51
Liquid biopsy in pancreatic cancer – Current perspective and future outlook
Zhao, Y., Tang, J., Jiang, K., Liu, S.-Y., Aicher, A., & Heeschen, C. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188868 · Cited by 56
Bugazia, D., Al-Najjar, E., Esmail, A., Abdelrahim, S., Abboud, K., Abdelrahim, A., Umoru, G., Rayyan, H. A., Abudayyeh, A., Moustafa, A. A., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1386699 · Cited by 51
Amaral, M. J., Oliveira, R. C., Donato, P., & Tralhão, J. G. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-07904-6 · Cited by 50
Clinical features and prognostic impact of asymptomatic pancreatic cancer
Takikawa, T., Kikuta, K., Hamada, S., Kume, K., Miura, S., Yoshida, N., Tanaka, Y., Matsumoto, R., Ikeda, M., Kataoka, F., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-08083-6 · Cited by 47
Søreide, K., Ismail, W., Roalsø, M. T. T., Ghotbi, J., & Zaharia, C. (2023) · Cancer Control · doi:10.1177/10732748231154711 · Cited by 48
Brand, R. E., Persson, J., Bratlie, S. O., Chung, D. C., Katona, B. W., Carrato, A., Castillo, M., Earl, J., Kokkola, A., Lucas, A. L., et al. (2022) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000468 · Cited by 46
Niedzielska, J., & Jastrzębski, T. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14093189 · Cited by 44
A blood-based metabolomic signature predictive of risk for pancreatic cancer
Irajizad, E., Kenney, A., Tang, T. M., Vykoukal, J., Wu, R., Murage, E. N., Dennison, J. B., Sans, M., Long, J. P., Loftus, M., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101194 · Cited by 46
Self-citationHe, L., Feng, A., Guo, H., Huang, H., Deng, Q., Zhao, E., & Yang, M. (2022) · Gastric Cancer · doi:10.1007/s10120-022-01279-9 · Cited by 44
Mannucci, A., & Goel, A. (2025) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.70035 · Cited by 54
Li, Z., Zhu, H.-B., Pang, X., Mao, Y. J., Yi, X., Li, C., Lei, M., Cheng, X., Liang, L., Wu, J., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-10051-2 · Cited by 40
Oldfield, L. S., Evans, A., Rao, R. G., Jenkinson, C., Purewal, T. S., Psarelli, E. E., Menon, U., Timms, J. F., Pereira, S. P., Ghaneh, P., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2021.103802 · Cited by 43
Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer
Ben‐Ami, R., Wang, Q.-L., Zhang, J., Supplee, J., Fahrmann, J. F., Lehmann‐Werman, R., Brais, L. K., Nowak, J. A., Yuan, C., Loftus, M., et al. (2023) · Gut · doi:10.1136/gutjnl-2023-331074 · Cited by 43
Self-citationDiagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges
Dbouk, M. H., Abe, T., Koi, C., Ando, Y., Saba, H., Diwan, E. A., Macgregor‐Das, A. M., Blackford, A. L., Mocci, E., Beierl, K. F., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0655 · Cited by 38
Biomarkers, omics and artificial intelligence for early detection of pancreatic cancer
Murray, K., Oldfield, L. S., Stefanova, I., Gentiluomo, M., Aretini, P., O’Sullivan, R., Greenhalf, W., Paiella, S., Aoki, M. N., Pastore, A., et al. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.02.009 · Cited by 38
Gong, Z., Lu, B., Wang, H., Ren, X. Z., Liu, X., Ma, H., Wu, D., Fan, D., & Wei, Q. L. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.3c04690 · Cited by 32
Haab, B. B., Qian, L., Staal, B., Jain, M., Fahrmann, J. F., Worthington, C., Prosser, D., Velokokhatnaya, L., Lopez, C., Tang, R., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217245 · Cited by 32
Self-citationEarly Detection of Pancreatic Cancer: Current Advances and Future Opportunities
Lin, Z., Adeniran, E. A., Cai, Y., Qureshi, T. A., Li, D., Gong, J., Li, J., Pandol, S. J., & Jiang, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13071733 · Cited by 34
Zhu, Z., Guo, Y., Liu, Y., Ding, R., Huang, Z., Yu, W., Cui, L., Du, P., Goel, A., & Liu, C. (2023) · Advanced Science · doi:10.1002/advs.202303378 · Cited by 29
Hinestrosa, J. P., Sears, R. C., Dhani, H., Lewis, J. M., Schroeder, G., Balcer, H. I., Keith, D., Sheppard, B. C., Kurzrock, R., & Billings, P. R. (2023) · Communications Medicine · doi:10.1038/s43856-023-00351-4 · Cited by 31
Qureshi, Z. A., Altaf, F., Khanzada, M., Safi, A., Asghar, Z., Warraich, D., & Shah, S. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002776 · Cited by 28
Organoid: Bridging the gap between basic research and clinical practice
Weng, G., Tao, J., Liu, Y., Qiu, J., Su, D., Wang, R., Luo, W., & Zhang, T. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216353 · Cited by 29
Early diagnosis of pancreatic cancer: What strategies to avoid a foretold catastrophe
Tonini, V., & Zanni, M. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i31.4235 · Cited by 27
Current status of molecular diagnostic approaches using liquid biopsy
Takahashi, K., Takeda, Y., Ono, Y., Isomoto, H., & Mizukami, Y. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-02024-4 · Cited by 26
Lucas, A. L., Simeone, D. M., Katona, B. W., Paiella, S., Zogopoulos, G., Sears, R. C., Grindedal, E. M., Wadlow, R. C., Borazanci, E. H., Gordon, O. K., et al. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.08.034 · Cited by 25
Self-citationDiagnostic Bioliquid Markers for Pancreatic Cancer: What We Have vs. What We Need
Liou, G., & Byrd, C. J. (2023) · Cancers · doi:10.3390/cancers15092446 · Cited by 25
The additive value of CA19.9 monitoring in a pancreatic cyst surveillance program
Levink, I. J. M., Jaarsma, S. C., Koopmann, B. D. M., van Riet, P. A., Overbeek, K. A., Meziani, J., Sprij, M. L. J. A., Casadei, R., Ingaldi, C., Polkowski, M., et al. (2023) · United European Gastroenterology Journal · doi:10.1002/ueg2.12422 · Cited by 23
Exosomes in Clinical Laboratory: From Biomarker Discovery to Diagnostic Implementation
Aljohani, M. A. (2025) · Medicina · doi:10.3390/medicina61111930 · Cited by 24
Early detection of pancreatic cancer: current state and future opportunities
Trikudanathan, G., Lou, E., Maitra, A., & Majumder, S. (2021) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000770 · Cited by 23
Self-citationScreening for pancreatic cancer has the potential to save lives, but is it practical?
Mazer, B. L., Lee, J. W., Roberts, N. J., Chu, L. C. H., Lennon, A. M., Klein, A. P., Eshleman, J. R., Fishman, E. K., Canto, M. I., Goggins, M., et al. (2023) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2023.2217354 · Cited by 24
The role of biomarkers in the early detection of pancreatic cancer
Goggins, M. (2024) · Familial Cancer · doi:10.1007/s10689-024-00381-4 · Cited by 28
Challenges of early detection of pancreatic cancer
Shen, M. J., Jamali, A., & Katona, B. W. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191942 · Cited by 24
Current Screening Strategies for Pancreatic Cancer
Vaněk, P., Urban, O., Zoundjiekpon, V., & Falt, P. (2022) · Biomedicines · doi:10.3390/biomedicines10092056 · Cited by 21
Oyama, H., Hamada, T., Nakai, Y., Tanaka, M. H., Takagi, K., Fukuda, R., Hakuta, R., Ishigaki, K., Kanai, S., Kawaguchi, Y., et al. (2024) · Annals of Surgery · doi:10.1097/sla.0000000000006268 · Cited by 18
Recent advances in understanding pancreatic cancer
Stott, M. C., Oldfield, L. S., Hale, J. J., Costello, E., & Halloran, C. M. (2022) · Faculty Reviews · doi:10.12703/r/11-9 · Cited by 19
Caban, M., & Małecka-Wojciesko, E. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164648 · Cited by 19
Liquid biopsy approach to pancreatic cancer
Perales, S., Torres, C., Jiménez‐Luna, C., Prados, J. C., Martínez-Galán, J., Sanchez-Manas, J. M., & Caba, O. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i10.1263 · Cited by 18
Engels, M. M. L., Berger, C. K., Mahoney, D. W., Hoogenboom, S. A. M., Sarwal, D., Klatte, D. C. F., de la Fuente, J., Gandhi, S., Taylor, W. R., Foote, P. H., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.07.048 · Cited by 17
Inherited Pancreatic Cancer Syndromes and High-Risk Screening
Biller, L. H., Wolpin, B. M., & Goggins, M. (2021) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2021.06.002 · Cited by 19
Self-citationDu, L., Min, H., Meng, Y., Zhang, K., Wang, L., Zhang, Y., Sun, P., Zhang, W., Qi, Y., & Wu, G. (2025) · Nano Letters · doi:10.1021/acs.nanolett.4c05354 · Cited by 18
Oyama, H., Hamada, T., Nakai, Y., Tanaka, M. H., Endo, G., Hakuta, R., Ishida, K., Ishigaki, K., Kanai, S., Kurihara, K., et al. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-02028-0 · Cited by 16
Smith, L. M., Mahoney, D. W., Bamlet, W. R., Yu, F., Liu, S., Goggins, M., Darabi, S., Majumder, S., Wang, Q.-L., Coté, G. A., et al. (2024) · Pancreatology · doi:10.1016/j.pan.2024.10.012 · Cited by 17
Self-citationPancreatic cancer risk predicted from disease trajectories using deep learningPreprint
Placido, D., Yuan, B., Hjaltelin, J. X., Zheng, C., Haue, A. D., Chmura, P. J., Yuan, C., Kim, J., Umeton, R., Antell, G. C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.27.449937 · Cited by 16
Self-citationctDNA in Pancreatic Adenocarcinoma: A Critical Appraisal
Ojha, S., Sessions, W. S., Zhou, Y., & Aung, K. L. (2025) · Current Oncology · doi:10.3390/curroncol32110589 · Cited by 15
Development of liquid biopsy in detection and screening of pancreatic cancer
Chen, X., Hu, X., & Liu, T. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1415260 · Cited by 18
Palieri, R., Luca, M. D., Balestra, F., Panzetta, G., Lotesoriere, C., Rizzi, F. R., Ricci, A. D., Mastrogiacomo, R., Curri, M. L., Laghi, L., et al. (2025) · Oncology Reviews · doi:10.3389/or.2025.1702932 · Cited by 17
Sagami, R., Sato, T., Mizukami, K., Motomura, M., Okamoto, K., Fukuchi, S., Otsuka, Y., Abe, T., Ono, H., Mori, K., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12020377 · Cited by 14
Microfluidic Barcode Biochips for High-Throughput Real-Time Biomolecule and Single-Cell Screening
Qiu, J., Liang, Y., Wang, C., Yu, Y., Zhang, Y., Liu, H., & Han, L. (2024) · Engineering · doi:10.1016/j.eng.2024.06.016 · Cited by 13
Levink, I. J. M., Klatte, D. C. F., Hanna-Sawires, R. G., Vreeker, G. C. M., Ibrahim, I. S., van der Burgt, Y. E. M., Overbeek, K. A., Koopmann, B. D. M., Cahen, D. L., Fuhler, G. M., et al. (2022) · Pancreatology · doi:10.1016/j.pan.2022.03.021 · Cited by 13
Janga, L. S. N., Sambe, H. G., Yasir, M. B., Man, R. K., Gogikar, A., Nanda, A., & Mohammed, L. (2023) · Cureus · doi:10.7759/cureus.44382 · Cited by 12
Circulating microRNAs in association with pancreatic cancer risk within 5 years
Wang, C., Cai, H., Cai, Q., Wu, J., Stolzenberg‐Solomon, R. Z., Guo, X., Zhu, C. S., Gao, Y., Berlin, J. D., Ye, F., et al. (2024) · International Journal of Cancer · doi:10.1002/ijc.34956 · Cited by 13
Mottini, C., Auciello, F. R., Manni, I., Pilarsky, C. P., Caputo, D. D., Caracciolo, G., Rossetta, A., Gennaro, E. D., Budillon, A., Blandino, G., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03117-5 · Cited by 12
Model-based screening for pancreatic cancer in Sweden
Draus, T., Ansari, D., & Andersson, R. E. (2022) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2022.2142481 · Cited by 12
Greco, L., Rubbino, F., & Laghi, L. (2022) · Cancers · doi:10.3390/cancers14235797 · Cited by 13
Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer
Bogdanski, A. M., van Hooft, J. E., Boekestijn, B., Bonsing, B. A., Wasser, M. N. J. M., Klatte, D. C. F., & van Leerdam, M. E. (2024) · Familial Cancer · doi:10.1007/s10689-024-00368-1 · Cited by 12
Zhou, D., Fan, X., Xie, S., Lu, M.-Y., Gao, L., Zhang, R., & Zhu, M. (2024) · Oncology Letters · doi:10.3892/ol.2024.14517 · Cited by 10
Wu, Y., Qiao, Y., Yang, C., Chen, Y., Shen, X., Deng, C., Yao, Q., & Sun, N. (2024) · Small Methods · doi:10.1002/smtd.202401238 · Cited by 10
Fan, D., Gong, Z., He, G., Liu, H., Wang, Y., Ma, H., Wu, D., Wang, H., & Wei, Q. L. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c05034 · Cited by 10
The dual role of gut microbiota in pancreatic cancer: new insights into onset and treatment
Cheng, H., Guo, H., Wen, C., Sun, G., Tang, F., & Li, Y. (2025) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359251324882 · Cited by 11
Metagenomic Microbial Signatures for Noninvasive Detection of Pancreatic Cancer
Chen, Y., Nian, F., Chen, J., Jiang, Q., Yuan, T., Feng, H., Shen, X., & Dong, L. (2025) · Biomedicines · doi:10.3390/biomedicines13041000 · Cited by 11
He, W., Cui, J., Wang, X.-Y., Siu, R. H. P., & Tanner, J. A. (2025) · Molecules · doi:10.3390/molecules30092012 · Cited by 10
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer
Modi, S., Kir, D., & Saluja, A. K. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.01.001 · Cited by 10
Takahashi, K., Inuzuka, T., Shimizu, Y., Sawamoto, K., Taniue, K., Ono, Y., Asai, F., Koyama, K., Sato, H., Kawabata, H., et al. (2024) · Pancreas · doi:10.1097/mpa.0000000000002315 · Cited by 9
Weselá, P., Eid, M., Moravčík, P., Vlažný, J., Hlavsa, J., Procházka, V., Kala, Z., & Vaňhara, P. (2025) · Cell Division · doi:10.1186/s13008-025-00158-w · Cited by 10
Das, K. K., & Brown, J. W. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1089028 · Cited by 7
Maher, M. H., Treekitkarnmongkol, W., Ghatak, S., Dai, J., Liu, S., Nguyen, T., Duose, D. Y., Kim, M. P., Hu, Y., Hurd, M. W., et al. (2025) · Cancer Cytopathology · doi:10.1002/cncy.70008 · Cited by 9
Self-citationPathological and molecular diagnoses of early cancer with bile and pancreatic juice
Kuwatani, M., & Sakamoto, N. (2022) · Digestive Endoscopy · doi:10.1111/den.14348 · Cited by 10
Zhu, W., Chen, L., Aphinyanaphongs, Y., Kastrinos, F., Simeone, D. M., Pochapin, M. B., Stender, C., Razavian, N., & Gonda, T. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-89607-8 · Cited by 8
Self-citationEstimating stage-specific sensitivity for cancer screening tests
Pinsky, P. F., Lange, J. M., & Etzioni, R. (2023) · Journal of Medical Screening · doi:10.1177/09691413231154801 · Cited by 8
The glycogene alterations and potential effects in esophageal squamous cell carcinoma
Feng, X., Chen, J., Lian, J., Dong, T., Gao, Y., Zhang, X., Zhai, Y., Zou, B., Guo, Y., Xu, E., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05534-3 · Cited by 8
Application of Mass Spectrometry in Pancreatic Cancer Translational Research
Ge, P., Luo, Y., Chen, H., Liu, J., Guo, H., Xu, C., Qu, J., Zhang, G., & Chen, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.667427 · Cited by 8
Jiang, D., Xiao, F., Liu, L., Meng, Z., & Zhang, C. (2022) · BioMed Research International · doi:10.1155/2022/6341381 · Cited by 8
Guidelines for holistic integrative management of pancreatic cancer
Yu, X. (2024) · Holistic Integrative Oncology · doi:10.1007/s44178-024-00097-6 · Cited by 7
Zhao, R., Yuan, H., Jiang, Y., Liu, Z., Chen, R., Wang, S., Lu, L., Yuan, Z., Su, Z., He, Q., et al. (2025) · Biomarker Research · doi:10.1186/s40364-025-00812-z · Cited by 11
Cost-Effectiveness of Biomarker-Associated Early Pancreatic Cancer Detection in New-Onset Diabetes
Stefanova, I., Thompson, N., Oldfield, L. S., Stott, M. C., Hanson, R., Palmer, D. H., Halloran, C. M., Greenhalf, W., Meer, R. V. D., & Costello, E. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.38031 · Cited by 7
Fahrmann, J. F., Yip-Schneider, M., Vykoukal, J., Spencer, R., Dennison, J. B., Do, K.-A., Long, J. P., Maitra, A., Zhang, J., Schmidt, C. M., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217450 · Cited by 7
Self-citationHao, J., Liu, W., Zhao, C., & Xia, T. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-2522 · Cited by 7
Heuriskance: a novel paradigm for systematic earlier detection of sporadic pancreatic cancer
Chari, S. T., Feng, Z., Wu, B. U., Fisher, W., Kambadakone, A. R., Zhao, Y., Maitra, A., Kenner, B. J., & Matrisian, L. M. (2025) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaf291 · Cited by 6
Self-citationBinkowski, B., Klamer, Z. L., Gao, C., Staal, B., Repesh, A., Tran, H.-L., Brass, D. M., Bartlett, P., Gallinger, S., Blomqvist, M., et al. (2025) · Science Advances · doi:10.1126/sciadv.adt0029 · Cited by 6
Li, M. (2021) · Journal of interventional medicine · doi:10.1016/j.jimed.2021.08.001 · Cited by 6
Kim, Y., Park, J., Park, E. Y., Kim, S., & Lee, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814301 · Cited by 6
Tarasiuk, A., Mirocha, G., & Fichna, J. (2023) · Current Treatment Options in Oncology · doi:10.1007/s11864-023-01146-4 · Cited by 6
Rosenthal, M. H., Wolpin, B. M., & Yurgelun, M. B. B. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.12.259 · Cited by 6
Self-citationDevelopment and Validation of a Parsimonious Risk Stratification Model for Pancreatic Cancer
Mavromatis, L. A., Zlatanic, V., Agarunov, E., Sanoba, S. A., Kluger, M. D., Horwitz, L. I., Razavian, N., Maitra, A., Gonda, T. A., & Grams, M. E. (2026) · JAMA Oncology · doi:10.1001/jamaoncol.2026.0372 · Cited by 5
Self-citationPotentially diagnostic and prognostic roles of piRNAs/PIWIs in pancreatic cancer: A review
Liu, Y., Li, C., Cui, X., Li, M., Liu, S., & Wang, Z. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189286 · Cited by 5
Yousefli, Z., Rafiee, N., Nourollahian, T., Alipour, A., Haghshenas, Z., Islampanah, M., Khazaei, M., Fiuji, H., Hassanian, S. M., Ferns, G. A., et al. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156045 · Cited by 5
Metadata
- Authors
- Fahrmann, J. F., Schmidt, C. M., Mao, X., Irajizad, E., Loftus, M., Zhang, J., Patel, N., Vykoukal, J., Dennison, J. B., Long, J. P., Do, K.-A., Zhang, J., Chabot, J. A., Kluger, M. D., Kastrinos, F., Brais, L., Babic, A., Jajoo, K., Lee, L. S., Clancy, T. E., Ng, K., Bullock, A., Genkinger, J., Yip-Schneider, M. T., Maitra, A., Wolpin, B. M., & Hanash, S.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Indiana University School of Medicine (US)
- Harvard University (US)
- Columbia University Irving Medical Center (US)
- Brigham and Women's Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Hanash, Samir
- ORCID
- Fahrmann, Johannes F.
- Schmidt, C. Max
- Mao, Xiangying
- Irajizad, Ehsan
- Loftus, Maureen
- Zhang, Jinming
- Dennison, Jennifer B.
- Long, James P.
- Do, Kim-Anh
- Zhang, Jianjun
- Kluger, Michael D.
- Kastrinos, Fay
- Brais, Lauren
- Lee, Linda S.
- Clancy, Thomas E.
- Ng, Kimmie
- Bullock, Andrea
- Genkinger, Jeanine
- Yip-Schneider, Michele T.
- Maitra, Anirban
- Wolpin, Brian M.
- Hanash, Samir
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 160
- Issue
- 4
- Pages
- 1373-1383.e6
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC8783758
- OpenAlex
- W3110895646
- Cited by
- 208
- References
- 56
- Citations by year
- 2026: 37 · 2025: 52 · 2024: 40 · 2023: 37 · 2022: 30 · 2021: 12
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Purdue University Indianapolis (Indiana University) (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute
- Pancreatic Cancer Action Network
- Lustgarten Foundation
- University of Texas MD Anderson Cancer Center
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- CA19-9, pancreatic cancer, early detection, liquid biopsy, circulating tumor markers, TIMP-1, LRG1, multimarker panels, pre-diagnostic biomarkers, chronic pancreatitis, pancreatic cysts, PLCO Cancer Screening Trial
- MeSH terms
- Liquid Biopsy, Aged, Diagnosis, Differential, Feasibility Studies, Female, Humans, Male, Mass Screening, Middle Aged, Pancreatic Cyst, Pancreatic Neoplasms, Sensitivity and Specificity, United States, CA-19-9 Antigen, Pancreatitis, Chronic, Early Detection of Cancer, Healthy Volunteers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
